Dishman Carbogen Amcis Ltd.
Snapshot View

99.90 +1.15 ▲1.2%

28 November 2022, 04:01:00 PM
Volume: 19,441

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.dishmangroup.com
Market Cap 1,568.61 Cr.
Enterprise Value(EV) 2,953.69 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.97 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 354.25 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.28 Calculated using Price: 99.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 15.68 Cr. 156,783,095 Shares
FaceValue 2
Company Profile
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.16%
1 Week
-0.65%
1 Month
+0.35%
3 Month
-16.19%
6 Month
-12.02%
1 Year
-56.32%
2 Year
-30.96%
5 Year
-66.62%
10 Year
6 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3,676.38 6.05 4.01 2.86 -2.89 0.32
Return on Capital Employed (%) 4.61 4.67 5.79 3.93 -0.26 0.76
Return on Assets (%) 2.23 2.25 2.90 2.04 -2.00 0.21

Balance Sheet View Details >>

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4,814 5,107 5,379 5,715 5,699 5,549 5,554
Non Curr. Liab. 767 884 743 909 1,367 1,665 1,644
Curr. Liab. 994 1,178 1,198 1,569 1,290 1,420 1,620
Minority Int.
Equity & Liab. 6,574 7,169 7,321 8,193 8,356 8,634 8,818
Non Curr. Assets 5,241 5,623 5,767 6,414 6,652 6,795 6,906
Curr. Assets 1,333 1,546 1,554 1,779 1,704 1,839 1,912
Misc. Exp. not W/O
Total Assets 6,574 7,169 7,321 8,193 8,356 8,634 8,818

Profit Loss View Details >>

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,714 1,695 2,059 2,044 1,912 2,141 2,286
Other Income 26 53 54 44 39 49 38
Total Income 1,740 1,748 2,112 2,088 1,951 2,190 2,324
Total Expenditure -1,260 -1,257 -1,507 -1,546 -1,638 -1,815 -1,987
PBIDT 479 491 606 542 313 375 336
Interest -49 -49 -57 -62 -48 -57 -70
Depreciation -214 -211 -240 -283 -308 -308 -313
Taxation -71 -76 -98 -39 -100 22 44
Exceptional Items -22 -15 -12
PAT 146 155 210 159 -165 18 -15
Minority Interest
Share Associate 1
Other Related Items
Consolidated Net Profit 147 155 210 159 -165 18 -15
Adjusted EPS 10 13 10 -11 1 -1

Cash Flow View Details >>

Particulars 6 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 303 226 282 585 513 355
Cash Fr. Inv. -142 -297 -169 -442 -380 -619
Cash Fr. Finan. -137 78 -102 -98 -11 130
Net Change 23 7 11 46 122 -133
Cash & Cash Eqvt 59 66 76 122 244 110

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 63.21 61.93 59.32 59.32 59.32 59.32 59.32 59.32 59.32
Public 36.79 38.07 40.68 40.68 40.68 40.68 40.68 40.68 40.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
DISCLOSURES OF RELATED PARTY TRANSACTIONS PURSUANT TO REGULATION 23 (9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS 2015
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose disclosure of Related Party Transactions of the Company in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2021 for the half year ended September 30 2022.
Wed, 16 Nov 2022
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 pls. find enclosed herewith transcript of earnings conference call arranged by the Company with Investors on Friday 11th November 2022 to discuss the financial result and performance of the Company for the quarter and half year ended on 30th September 2022.The aforesaid transcript is also being hosted on the website of the Company www.imdcal.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
Fri, 11 Nov 2022
UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS' LIMITED REVIEW REPORT FOR THE QUARTER AND HALF YEAR ENDED 30/09/2022
As per Regulation 30 and 33 of SEBI (LODR) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Friday the 11th day of November 2022 which was commenced at 1:00 P.M. and concluded at 03:35 P.M. inter alia to consider and take on record the Un-audited Financial Results of the Company for the quarter and half year ended on 30th September 2022 along with Statutory Auditors Limited Review Report dated 11th day of November 2022 issued by M/s. T R Chadha & Co. LLP Chartered Accountants in respect of the Un-audited Financial Results of the Company for the quarter and half year ended on 30th September 2022 prepared in terms of Regulation 33 of SEBI (LODR) Regulations 2015.

At the said Board Meeting the said Un-audited Financial Results alongwith Limited Review Report were adopted and approved which are attached herewith.

Technical Scans View Details >>

Mon, 28 Nov 2022
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 3 Months High Decrease 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Dishman Carbogen Amcis Ltd.

What is Dishman Carbogen Amc share price?

Can I buy Dishman Carbogen Amc shares now?

What is the Market Cap of Dishman Carbogen Amc?

What are the key metrics to analyse Dishman Carbogen Amc?

What is the 52 Week High and Low of Dishman Carbogen Amc?

What is the trend of Dishman Carbogen Amc share price?